Clinical trials
Phase 4 Shock, Septic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 7 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Unknown status | 14 |
| Recruiting | 11 |
| Terminated | 10 |
| Not yet recruiting | 4 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Southeast University, China | 5 |
| Cairo University | 3 |
| Ain Shams University | 2 |
| Asan Medical Center | 2 |
| First Affiliated Hospital of Wannan Medical College | 2 |
| Peking Union Medical College Hospital | 2 |
| Sutep Jaruratanasirikul | 2 |
| The Cleveland Clinic | 2 |
| University of New Mexico | 2 |
| Alexander Flannery | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Septic | 80 |
| Sepsis | 40 |
| Diabetes Insipidus | 7 |
| Shock | 5 |
| Acute Kidney Injury | 4 |
| Critical Illness | 4 |
| Gram-Negative Bacterial Infections | 2 |
| Liver Cirrhosis | 2 |
| Multiple Organ Failure | 2 |
| Systemic Inflammatory Response Syndrome | 2 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.